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Abstract
Oral cholera vaccines (OCVs) are relatively new public health interventions, and limited
data exist on the potential impact of OCV use on traditional cholera prevention and control
measures—safe water, sanitation and hygiene (WaSH). To assess OCV acceptability and
knowledge, attitudes, and practices (KAPs) regarding cholera and WaSH, we conducted
cross-sectional surveys, 1 month before (baseline) and 3 and 12 months after (first and sec-
ond follow-up) a preemptive OCV campaign in Maela, a long-standing refugee camp on the
Thailand-Burma border. We randomly selected households for the surveys, and adminis-
tered questionnaires to female heads of households. In total, 271 (77%), 187 (81%), and
199 (85%) households were included in the baseline, first and second follow-up surveys,
respectively. Anticipated OCV acceptability was 97% at baseline, and 91% and 85% of
household members were reported to have received 1 and 2 OCV doses at first follow-up.
Compared with baseline, statistically significant differences (95% Wald confidence interval
not overlapping zero) were noted at first and second follow-up among the proportions of
respondents who correctly identified two or more means of cholera prevention (62% versus
78% and 80%), reported boiling or treating drinking water (19% versus 44% and 69%), and
washing hands with soap (66% versus 77% and 85%); a significant difference was also
observed in the proportion of households with soap available at handwashing areas (84%
versus 90% and 95%), consistent with reported behaviors. No significant difference was
noted in the proportion of households testing positive for Escherichia coli in stored house-
hold drinking water at second follow-up (39% versus 49% and 34%). Overall, we observed
some positive, and no negative changes in cholera- and WaSH-related KAPs after an OCV
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campaign in Maela refugee camp. OCV campaigns may provide opportunities to reinforce
beneficial WaSH-related KAPs for comprehensive cholera prevention and control.
Author Summary
Safe water, sanitation, and hygiene (WaSH) are the primary measures for cholera preven-
tion and control. Since 2010, oral cholera vaccines (OCVs) have been recommended as an
additional tool for endemic and epidemic cholera prevention and control. Given the rela-
tively new use of OCVs in public health programs, there is limited information on the
impact of OCV use on traditional WaSH activities, i.e., can they serve as complementary
tools, or will OCV use have a negative impact on WaSH-related behaviors? This study
reports the findings of knowledge, attitudes and practices (KAP) surveys conducted before
and after a preventive OCV campaign (2013) in a long-standing refugee camp in Thai-
land, where frequent cholera outbreaks had occurred in recent years. The surveys demon-
strated high acceptability of the OCV campaign and several modest improvements in
cholera and WaSH KAPs among the camp population. OCV campaigns may be used as
opportunities to reinforce cholera and WaSH-related messaging towards strengthening
comprehensive cholera prevention and control.
Introduction
Cholera causes an estimated 2.9 million illnesses and 94,000 deaths annually, mostly in Asia
and sub-Saharan Africa [1]. Cholera is caused by ingestion of food or water contaminated with
feces containing toxigenic strains of Vibrio cholerae serogroups O1 and O139, and the illness is
characterized by profuse watery diarrhea, vomiting, and dehydration. Case-fatality rates can
exceed 70%, but can be as low as<1% if rehydration treatment is instituted rapidly and effec-
tively [2].
Safe water, sanitation, and hygiene (WaSH), and effective cholera treatment are the main-
stay of cholera prevention and control. In addition, two safe and effective oral cholera vaccines
(OCV) are available globally; both are 2-dose, killed whole-cell vaccines. Shanchol (Shantha
Biotechnics, India; now Sanofi) is a bivalent OCV (O1 and O139) that was first licensed in
2009 and prequalified by WHO in 2011 and is cheaper and easier to administer (i.e., not
requiring water for buffer) than the previously licensed monovalent (O1) OCV. Moderate-to-
high vaccine efficacy and field effectiveness has been demonstrated in multiple settings, includ-
ing 67% efficacy over 5 years in an endemic area and 86% effectiveness during an acute out-
break [3, 4]. Since 2010, OCVs have been recommended by the World Health Organization
(WHO) as an additional tool for control of endemic and epidemic cholera [5]. OCV cam-
paigns have been conducted in multiple settings [6–14], including refugee camps in Uganda,
South Sudan, and Tanzania [15–18].
In Maela, a long-standing refugee camp in Thailand, four cholera outbreaks occurred dur-
ing 2005–2010, with an incidence of 0.7–10.7 cases per 1,000 refugees per year [19]. Multiple
partners have conducted outbreak response activities which have included enhanced surveil-
lance with active case finding, case management, and WASH interventions, including hygiene
promotion, and distribution of soap, chlorine and covered water containers (C. Deglise, per-
sonal communication). After the 2010 outbreak, a decision was made to use OCV in Maela to
further reduce the risk of cholera outbreaks in the camp [20]. During January–March 2013, a
Oral Cholera Vaccination Campaign KAP Survey, Thailand
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2-dose OCV campaign with Shanchol was conducted, targeting all eligible 43,485 Maela resi-
dents (1 year of age and not pregnant) [19].
During 2010–2012, OCVs were a relatively new intervention, with limited data on the
potential impact of vaccine use on WaSH measures, leading to concerns raised on the potential
for OCV to detract from proven methods of cholera prevention and control [21]. In 2012, a
WHO Technical Working Group on Creation of an OCV Stockpile recommended evaluation
of OCV acceptability and impact on WaSH activities and created specific guidance on con-
ducting knowledge, attitudes and practice (KAP) surveys during OCV campaigns [22, 23]. To
assess the short- and long-term impact of an OCV intervention campaign and associated mes-
saging on WaSH KAPs among the Maela camp population, we conducted household surveys 1
month before, and 3 and 12 months after the OCV campaign. We evaluated anticipated OCV
acceptability before the campaign, campaign awareness and OCV uptake after the campaign,
changes over time in reported knowledge, beliefs, and behaviors regarding cholera, WaSH and




Refugee camp. Maela camp was established in 1984, under management of the Royal
Thai Government’s Ministry of the Interior, and provides shelter for approximately 46,000 ref-
ugees from Burma, predominately of Karen ethnicity [19]. Several essential services are pro-
vided by non-governmental organizations. At the time of the campaign and surveys, these
organizations included The Border Consortium (TBC) (food and shelter rations), Première
Urgence-Aide Médicale Internationale (PU-AMI) (clinical health services at two camp facili-
ties, preventive care, public health, and outbreak response), and Solidarités International (SI)
(WaSH services, including chlorinating and testing water sources, building latrines, and pro-
viding WaSH education and materials). Population density in the camp is high (11,500 persons
per km2), and the existing infrastructure for improved water and sanitation is limited because
of the intended temporary status of the camp [19]. One-third of camp residents use water
sources, such as natural springs, private water networks, and water sellers, which are known to
be less safe [19]. Mobility of the camp population is high [19].
OCV campaign and associated messaging. The 2-dose OCV campaign in Maela camp
was implemented by PU-AMI with technical assistance by the U.S. Centers for Disease Con-
trol and Prevention (CDC) in three rounds during January–March 2013, with support from
the Thailand Ministry of Public Health (MOPH) and the Bill and Melinda Gates Foundation
[19]. Before the OCV campaign, barcoded vaccination cards with names were distributed to
each camp resident. During the campaign, individual cards were scanned and manually date-
stamped for each dose received; temporary cards were provided for anyone not bringing a vac-
cine card. A vaccination registry was created based on this documentation (18).
Immediately after the baseline KAP survey in December 2012, PU-AMI delivered informa-
tion about the OCV campaign to camp leaders in meetings and to the community through
posters, school presentations, loud-speaker announcements, and household visits, as described
previously [19]. Documentation of campaign-associated messaging was reviewed and found to
include reference to information about OCV (e.g., 2-dose requirement, limited vaccine efficacy
and duration of immunity), handwashing, and cholera prevention practices (other than hand-
washing posters, documentation of specific cholera prevention message content was unavail-
able). Routine provision of WaSH services by SI (the water and sanitation NGO) continued
per their mandate, and no additional WaSH interventions were conducted before, during, or
Oral Cholera Vaccination Campaign KAP Survey, Thailand
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immediately after the OCV campaign. Between 3 and 12 months following the campaign, SI
conducted additional WaSH educational activities, including dramatic performances on chol-
era prevention, hand washing campaigns, and screenings of “The Story of Cholera” film by the
Global Health Media Project (F. Cavalazzi, personal communication), but the extent of these
activities could not be determined.
Survey methodology
We conducted cross-sectional household-level surveys 1 month before the OCV campaign
during November–December 2012 (baseline), 3 months after the campaign during May–June
2013 (first follow-up), and 12 months after the campaign in March 2014 (second follow-up). A
household was defined as all persons living under one roof and sharing a “ration book” used
for obtaining camp rations. For each survey, households were selected by simple random sam-
pling from the most recent camp census, representing approximately 8,000 households [19].
All households living in the camp at least 1 month prior to the campaign were eligible for the
survey. Households selected in the baseline or first follow-up survey remained eligible for
selection in subsequent survey(s). Boarding houses for students were excluded from all sur-
veys. Sample size was calculated using PASS 2008 (NCSS, Kaysville, UT) based on a Z-test
(pooled variance) to detect a difference between two proportions as 350 households for the
baseline and 200 households for both follow-up surveys, assuming a 50% baseline outcome
and 15% change (α = 0.05, power = 89). Because non-response in the baseline survey was
higher than expected (23% vs. 15%), the sample size of the follow-up surveys was revised to
233 households.
The survey was conducted by Maela refugees who were trained and working as PU-AMI
community health workers (CHWs). Interviewers visited the household up to three times to
attempt to enroll the female head of the household aged18 years, or another adult if she was
unavailable; non-responding households were not replaced. Interviews were conducted in
Karen or Burmese language using a pre-tested, structured questionnaire including socio-
demographic information, and KAPs regarding cholera, WaSH, immunization, and OCV
acceptability; also included were observations about household characteristics, including water
containers, handwashing stations, and latrines. OCV campaign vaccination status of all house-
hold members was first documented by recall of the household respondent and second, by
review of available campaign vaccination cards.
Ethics statement
This evaluation was determined to be a public health program evaluation activity according to
the U.S. CDC’s human subjects’ procedures and approved by the Ethics Committee for
Research in Human Subjects at the Thailand MOPH Department of Disease Control. Written
informed consent was collected from all participants by signature or thumb print. Only adults
aged18 years were intended to be interviewed, but in some cases, interviewers mistakenly
enrolled female heads of household aged<18 years. In Burma, the country of origin for survey
interviewers and participants, the age of legal adulthood is 16 years, rather than 18 years, and
most of the under-age respondents were16 years old. While data on marital status was not
collected during the survey, it is likely that these women, who self-identified themselves as
female heads of households, were married women. In several countries including the United
States, marriage is a special circumstance for minors to be considered as ’emancipated minors’
(legally considered adults). Hence, no attempt was made to obtain consent from the parents of
these women.
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Laboratory methods
As an objective measure of drinking water quality, stored household drinking water was col-
lected and tested for residual chlorine and fecal contamination on the day of the survey visit.
Interviewers tested a 5 ml water sample for residual chlorine using N, N diethyl-p-phenylene-
diamine sulfate (LaMotte, Chestertown, MD) and collected a 100 ml water sample in a Whirl-
Pak bag with sodium thiosulfate (Nasco, Fort Atkinson, WI), using sterile technique. The sec-
ond sample was transported on ice (2–8˚C) for off-site microbial testing using Colisure media
(IDEXX Laboratories, Westbrook, ME). After incubating for 24–48 hours at 35˚C, samples
were recorded as positive or negative for Escherichia coli, per the manufacturer’s protocol.
Data analysis
Data were analyzed using SAS version 9.3 (SAS Institute, Cary, NC). We performed a descrip-
tive analysis of the baseline survey, including socio-demographic characteristics and cholera,
WaSH, and immunization KAPs. The first and second follow-up surveys were each compared
with baseline. For binary outcomes, we calculated absolute differences in proportions with
95% Wald asymptotic confidence intervals (CIs); differences were judged to be significant if
their CIs did not overlap zero. For continuous outcomes, we used Wilcoxon two-sample tests.
OCV coverage estimates and 95% Wilson CI were calculated using Taylor series linearization
method to account for intra-household correlation. Definitions for constructed variables such
as “knowing two or more means of cholera transmission” are given as footnotes in the tables.
Results
Characteristics of the survey samples
A total of 271 (77%), 187 (81%) and 199 (85%) households were enrolled in the baseline, first
follow-up and second follow-up surveys, respectively. Reasons for survey non-response are
listed in Table 1. At baseline, median duration of camp residency was 8 years (range: 1–31),
and median household size was 5 persons (range: 1–15). Among survey respondents, 206
(77%) were female with a median age of 39 years (range: 15–77 years); 213 (79%) were of
Karen ethnicity, and 107 (40%) had never attended school. Overall, 44% of households had
electricity, and most used squat or pour-flush toilets (74% and 16%, respectively) (Table 2).
No differences were observed between the baseline and first or second follow-up surveys in
household demographic characteristics or ownership of most durable consumer goods
(Table 2). The proportion of households owning a mobile phone increased 8% (95% CI: 1%–
14%) between the baseline and first follow-up survey; because mobile phone ownership was
Table 1. Reasons for household non-response in the surveys conducted 1 month before (baseline), and 3 and 12 months after (first and second
follow-up) an oral cholera vaccination campaign, Maela Camp, 2013.
Reason for non-response Baseline 1st follow-up 2nd follow-up
No. % No. % No. %
Temporarily lived/worked outside camp 32 40 10 22 16 47
No longer lived in camp 28 35 12 26 14 41
Not home 15 19 11 24 1 3
Could not be located 2 3 11 24 2 6
Refused - - 1 2 1 3
Ineligible (arrived <1 month before campaign) - - 1 2 - -
Reason not recorded 2 3 - - - -
Total 79 100 46 100 34 100
doi:10.1371/journal.pntd.0005210.t001
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not deemed to be a primary indicator of socio-economic status for a household, an adjusted
analysis was not performed.
Cholera and WaSH knowledge
At baseline, 218 (81%) of 270 respondents had heard about cholera; of these, 114 (52%) men-
tioned watery diarrhea as a symptom of cholera. Overall, 133 (61%) of 218 respondents knew
two or more vehicles of cholera transmission, and 136 (62%) knew two or more means of chol-
era prevention. Most respondents (97%) reported they would go to the camp clinic for cholera
treatment; no respondents mentioned using oral rehydration solution (ORS). A total of 182
Table 2. Socio-demographic characteristics of respondent households in the surveys conducted 1
month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vacci-
nation campaign, Maela Camp, 2013.
Characteristic Baseline 1st follow-up 2nd follow-up
(n = 271)a (n = 187)a (n = 199)a
No. % No. % No. %
Households with child aged <5 years 141 52 101 54 108 54
Households with child aged 5–14 years 190 70 135 72 137 69
Female 206 77 142 76 153 77
Ethnicityb
Karen 213 79 156 84 165 83
Burmese 11 4 0 0 1 1
Muslimc 36 13 24 13 28 14
Other 11 4 6 3 5 3
Educationd
No school 107 40 67 36 78 39
Some primary school 90 33 44 24 61 31
Some middle school 29 11 28 15 28 14
Some high school or higher 44 16 45 24 30 15
Electricity 118 44 79 42 101 51
Own TV 104 39 64 35 92 46
Own mobile phone 218 80 164 88 163 82
Share a toilet with other households 16 6 17 9 20 10
Toilete
Pour flush toilet 43 16 38 20 24 12
Squat toilet 201 74 120 64 157 79
Pit latrine 22 8 24 13 15 8
Other 4 1 5 3 3 2
Median (range) Median (range) Median (range)
Median duration of camp residency (years) 8 (1–31) 8 (1–33) 9 (1–29)
Median household size 5 (1–15) 5 (1–26) 6 (1–23)
Median age (years) 39 (15–77) 38 (17–88) 38 (16–76)
a Missing data resulted in small fluctuations in denominators for some responses
b For statistical analysis, ethnicity was computed as a binary outcome (Karen vs. non-Karen)
c In the camp, "Muslim" is a widely identified ethnicity, in addition to being a religion
d For statistical analysis, education was computed as a binary outcome (some school vs. no school)
e For statistical analysis, toilet was computed as a binary outcome (pour flush and squat toilet vs. pit latrine
and other)
doi:10.1371/journal.pntd.0005210.t002
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(83%) of 218 respondents reported having heard about cholera prevention and treatment from
other people or the media; of those, most (77%) received the information from health workers
visiting the home, and most (91%) received materials for protecting their household against
cholera (Table 3).
Compared with baseline, the proportion of respondents in the first follow-up survey who
knew two or more means of cholera prevention increased 15% (95% CI: 6%–24%), and those
who knew about boiling or treating drinking water for cholera prevention increased 13% (95%
CI: 3%–23%). The proportion who reported they would use ORS for cholera treatment
increased 7% (95% CI: 3%–11%) (Table 3 and Fig 1). Though the proportion of respondents
Table 3. Knowledge and practices about safe water, sanitation and hygiene in surveys conducted 1
month before (baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vacci-
nation campaign, Maela Camp, 2013.
Knowledge Baseline 1st follow-up 2nd follow-up
(n = 271)a (n = 187)a (n = 199)a
No. % No. % No. %
Heard of cholera 218 81 152 81 181 91
Knew that watery diarrhea was a symptom of cholera 114 52 68 45 95 52
Knew 2 vehicles of cholera transmissionb 133 61 90 59 148 82
Knew 2 means of cholera preventionc 136 62 118 78 144 80
Knew about boiling or treating drinking water for cholera prevention 115 53 100 66 96 53
Knew about washing hands with soap for cholera prevention 107 49 66 43 97 54
Knew about cooking food thoroughly for cholera prevention 101 46 78 51 103 57
Reported would go to clinic for cholera treatment 211 97 151 99 181 100
Reported would use oral rehydration for cholera treatment 0 0 10 7 10 6
Heard about preventing and treating cholera from people or media 182 83 124 82 166 92
Received soap to prevent cholera 150 83 94 76 135 81
Received chlorine solution to prevent cholera 62 34 15 12 28 17
Received water container to prevent cholera 40 22 8 6 23 14
Received printed educational materials to prevent cholera 18 10 3 2 49 30
Practice
Reported camp water tap as primary drinking water source 180 67 144 77 138 70
Reported boils or treats drinking waterd 51 19 83 44 137 69
Reported boiling or treating drinking water within last 24 hoursd 32 12 54 29 122 61
Reported washing hands 3 types of occasionse 133 49 93 50 134 67
Reported washing hands before eating and after using the toilet 124 46 99 53 123 62
Reported using soap to wash hands 178 66 143 77 170 85
Observed soap at hand-washing station 227 84 168 90 188 95
Observed covered drinking water container with spigot 195 73 118 63 130 65
Observed residual chlorine in household drinking water sample 22 8 8 4 3 2
Observed E. coli in household drinking water sample 106 39 91 49 68 34
a Missing data resulted in small fluctuations in denominators for some responses
b Drinking bad water, eating bad food, eating foods or drinks prepared outside the home, not washing fruits
and vegetables, not cooking food thoroughly, flies/insects, poor hygiene/hand-washing, and eating raw fish
c Wash hands with soap and water, cook food thoroughly, drink water from public tap, boil/filter drinking
water, treat water with chlorine, wash fruits/vegetables, clean cooking utensils/vessels, dispose of human
waste properly, and cover food to keep away flies
d Limited comparibility between baseline and 3-month follow-up, or baseline and 1 year follow-up due to
changes in translation made after the baseline survey
e After using toilet, after washing/cleaning tables, before eating, after eating, after cleaning baby diapers/
stools, before cooking
doi:10.1371/journal.pntd.0005210.t003
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who reported hearing about cholera prevention and treatment from other people or the media
was unchanged, reported receipt of materials to prevent cholera decreased, including receipt
of chlorine solution (22% [95% CI: 13%–33%]), water containers (16% [95% CI: 8%–23%]),
and printed education materials (8% [95% CI: 2%–13%]); reported receipt of soap was
unchanged (Table 3).
In the second follow-up survey, changes in cholera and WaSH knowledge that were sus-
tained from the first follow-up survey included a 17% (95% CI: 8%–26%) increase in the pro-
portion of respondents who knew two or more means of cholera prevention; a 6% (95% CI:
2%–9%) increase in those reporting they would use ORS for cholera treatment; and a 17%
(95% CI: 8%–26%) and 8% (95% CI: 0%–16%) decrease in reported receipt of chlorine solution
and water containers compared to baseline, respectively. Changes observed in the second fol-
low-up survey, but not in the first follow-up survey, included that 10% (95% CI: 4%–16%)
more respondents reported having heard about cholera; 21% (95% CI: 12%–29%) more men-
tioned two or more vehicles of cholera transmission; 3% (95% CI: 1%–6%) more reported they
would go to the clinic for cholera treatment; and 8% (95% CI: 2%–15%) more reported having
heard about cholera prevention and treatment from other people or the media, with 20% (95%
CI: 11%–28%) more reporting receipt of printed materials, compared with baseline (Table 3
and Fig 1).
Fig 1. Differences in knowledge, attitudes and practices (KAPs) for surveys conducted 1 month before (baseline) versus 3 and 12 months
after (first and second follow-up) an oral cholera vaccination campaign in Maela Camp, 2013. Absolute differences in proportions for KAP
responses in the first and second follow-up surveys compared to baseline were calculated; error bars depict 95% Wald asymptotic confidence interval
(CI). Statistically significant differences (CI not overlapping zero) are shown in grey; non-significant differences are shown in white. Outcomes marked
with * have directionality of difference switched from Tables 3 and 4, so that improvements are depicted in positive direction, and negative changes are
depicted in negative direction.
doi:10.1371/journal.pntd.0005210.g001
Oral Cholera Vaccination Campaign KAP Survey, Thailand
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WaSH practices
At baseline, 180 (67%) of 270 respondents reported the camp public tap as their primary
household drinking water source. Overall, 51 (19%) households reported boiling or treating
drinking water to make it safer, and 32 (12%) reported doing so in the last 24 hours. For house-
holds that reported not boiling or treating their water, 89% reported that they believed that
their “water source is safe and does not need treatment.” A total of 133 (49%) respondents
reported washing hands on at least three types of occasions, and 178 (66%) reported using
soap to wash hands; soap was observed at the place for handwashing in 227 (84%) households.
Safe water containers, defined as covered water containers with spigots, were observed in 195
(73%) of 268 households. Among the 271 households surveyed, residual chlorine was detected
in 22 (8%) households’ stored drinking water and E. coli contamination was detected in 106
(39%) (Table 3).
Compared with baseline, 10% (95% CI: 2%–19%) more respondents in the first follow-up
survey reported using the camp public tap as their primary drinking water source. The propor-
tion of households that reported boiling or treating drinking water increased 25% (95% CI:
17%–34%), and those that reported doing so in the last 24 hours increased 17% (95% CI: 9%–
25%); however, a difference in translation for these questions between the baseline and follow-
up surveys limits comparability. Reported use of soap to wash hands increased 11% (95% CI:
2%–19%), and observed soap at handwashing stations increased 6% (95% CI: 0%–12%). At
first follow-up compared with baseline, safe water containers were observed in 10% (95% CI:
1%–18%) fewer households, and 10% (95% CI: 1%–19%) more households had E. coli contam-
ination of stored drinking water (Table 3 and Fig 1). E. coli contamination of stored household
drinking water was associated with a lack of safe water containers in the first follow-up survey
(p = 0.006).
In the second follow-up survey, changes in WaSH knowledge and practices that were sus-
tained from the first follow-up survey included a 50% (95% CI: 42%–58%) increase in the pro-
portion who reported boiling or treating their drinking water and a 50% (95% CI: 41%–57%)
increase in those who reported doing so in the last 24 hours (between the first and second fol-
low-up surveys, where translation of these questions was comparable, increases of 24% [95%
CI: 15–34%] and 32% [95% CI: 23–42%] were observed, respectively). Other sustained changes
in the second follow-up survey, compared with baseline, were a 19% (95% CI: 12%–27%)
increase in reported use of soap to wash hands and an 11% (95% CI: 6%–16%) increase in soap
observed at handwashing stations. Changes observed in the second follow-up survey, but not
in the first follow-up survey, included 18% (95% CI: 9%–27%) more respondents who reported
washing hands on at least three types of occasions and 7% (95% CI: 3%–10%) fewer house-
holds with residual chlorine detected in stored drinking water samples, compared with base-
line (Table 3 and Fig 1).
Vaccine knowledge, attitudes, and practices
At baseline, 135 (50%) of 271 respondents could name two or more diseases prevented by vac-
cines, and 107 (39%) respondents claimed to have heard of “cholera vaccine.” Overall, 11 (4%)
respondents reported having any concerns about adults in the household receiving vaccines,
and 17 (7%) reported concerns about children in the household receiving vaccines. In total,
231 (86%) of 271 respondents reported a household member receiving any vaccine; 220 (97%)
and 217 (95%) of 228 respondents reported a child in the household receiving polio drops and
a measles injection, respectively (Table 4).
Compared with baseline, the proportion of respondents in the first follow-up survey men-
tioning cholera as a disease they knew to be prevented by vaccine increased 19% (95% CI:
Oral Cholera Vaccination Campaign KAP Survey, Thailand
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11%–26%), and those reporting they had heard of “cholera vaccine” increased 55% (95% CI:
48%–61%). In the second follow-up survey, changes in vaccine KAPs that were sustained from
the first follow-up survey relative to baseline included a 27% (95% CI: 19%–35%) increase in
the proportion of respondents who named cholera as a disease prevented by vaccine, and a
53% (95% CI: 47%–60%) increase in those who had heard of “cholera vaccine.” Changes
observed in the second follow-up survey, but not in the first follow-up survey, included 19%
(95% CI: 10%–27%) more respondents mentioning two or more diseases prevented by vac-
cines and 6% (95% CI: 2%–10%) fewer respondents reporting concerns about children in the
household receiving vaccines, compared to baseline.
OCV acceptability and uptake. At baseline, 262 (97%) of 271 respondents reported will-
ingness to receive OCV, and 221 (97%) of 228 of respondents with children reported willing-
ness to let their child receive OCV. At first follow-up, 184 (99%) of 187 respondents reporting
awareness of the OCV campaign. The most commonly reported source of information about
the campaign was health workers visiting the home (45%). When respondents were questioned
about the duration and level of protection of OCV, 86 (49%) expected up to 2 years, and 23
(13%) expected 3–5 years of protection from cholera; 101 (54%) expected the vaccine would be
“somewhat protective, with other protective measures needed” (Table 5).
Overall, 186 (99%) of respondents reported at least one household member receiving OCV
during the campaign; 70 (38%) reported non-vaccination of at least one household member;
and 35 (19%) reported at least one household member receiving only 1 dose. Absence from
the camp was the most commonly reported reason both for non-vaccination (14%) and receipt
of only 1 OCV dose (6%), besides non-eligibility. Few (1%) respondents reported a household
member spitting out part of the vaccine. Overall, 17 (9%) of 187 respondents reported adverse
events following campaign vaccination in a household member (Table 5).
Overall, OCV coverage by respondents’ recall was 91% (95% CI: 88%–93%) for the first
dose and 85% (95% CI: 81%–89%) for the second dose, among the 1,102 individuals aged1
Table 4. Knowledge, attitudes and practices about vaccination in surveys conducted 1 month before
(baseline), and 3 and 12 months after (first and second follow-up) an oral cholera vaccination cam-
paign, Maela Camp, 2013.
Knowledge and attitude Baseline 1st follow-up 2nd follow-up
(n = 271)a (n = 187)a (n = 199)a
No. % No. % No. %
Knew 2 diseases prevented by vaccinesb 135 50 98 52 136 68
Knew measles prevented by vaccine 115 42 82 44 100 50
Knew polio prevented by vaccine 101 37 65 35 97 49
Knew cholera prevented by vaccine 31 11 56 30 77 39
Heard of cholera vaccine 107 39 176 94 185 93
Concerns about household adults receiving vaccines 11 4 4 2 3 2
Concerns about household children receiving vaccinesc 17 7 8 5 2 1
Practice
Reported household member received any vaccine 231 86 161 86 192 96
Reported child aged <15 years received polio dropsc 220 97 158 98 161 100
Reported child aged <15 years received measles injectionc 217 95 152 94 153 95
a Missing data resulted in small fluctuations in denominators for some responses
b Cholera, diarrhea, tuberculosis, hepatitis, diphtheria, pneumonia, tetanus, meningitis, whooping cough
(pertussis), measles, polio, chickenpox, and typhoid
c Number of households without children was 43 in baseline, 38 in 1st follow-up, and 25 in 2nd follow-up
doi:10.1371/journal.pntd.0005210.t004
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Table 5. Oral cholera vaccination (OCV) acceptability 1 month before the campaign (baseline) and
campaign awareness and OCV uptake 3 months after the campaign (first follow-up), Maela Camp,
2013.
Baseline (n = 271) No. %
Willing to receive cholera vaccine 262 97
Willing to let child receive cholera vaccinea 221 97
1st follow-up (n = 187)b
Heard of cholera vaccine campaign 184 99
Health worker visiting home 85 45
Section leader 68 36
Staff at the clinic 48 26
Megaphone/loudspeaker 23 12
Neighbor or friend 22 12
Poster 21 11
A meeting in the camp 18 10
Other 6 3
Expected duration of protection of cholera vaccine
Up to 2 years 86 49
From 3–5 years 23 13
From 6–10 years 4 2
Lifetime 24 14
Don’t know 39 22
Expected level of protection of vaccine
Completely protective, no other measures needed 80 43
Somewhat protective, some other measures needed 101 54
Not protective, other measures needed 1 1
No measures can prevent cholera - -
Don’t know 4 2
Reported household member received vaccine 186 99
Reported household member didn’t receive vaccine 70 38
Not old enough for vaccine 30 16
Absence 26 14
Pregnant during campaign 14 7
Busy/no time 10 5
Sick during campaign 7 4
Bad taste of vaccine 1 1
Other 7 4
Reported household member received only one dose 35 19
Absence 12 6
Busy/no time 6 3
Sick during campaign 6 3
Adverse event after 1st dose 4 2
Forgot to go 3 2
Bad taste of vaccine 2 1
Other 6 3
Reported household member spit out part of vaccine 2 1
Reported household member had adverse event 17 9
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year in households surveyed at first follow-up. Vaccination cards were available for 443 (40%)
individuals. OCV coverage by card, among individuals with available documentation, was
93% (95% CI: 89%–96%) for the first dose and 84% (95% CI: 78%–89%) for the second dose
(Table 6). Assuming that all 203 individuals in the 46 non-responding households were unvac-
cinated, OCV coverage in the camp overall could have been as low as 77% (95% CI: 72%–82%)
and 72% (95% CI: 67%–77%) for the first and second dose, respectively.
Discussion
To our knowledge, this was the first evaluation of the short and long-term impact of an OCV
campaign and associated messaging on KAPs regarding cholera, WaSH, and OCV through
inclusion of surveys at three time points (1 month before, and 3 and 12 months after the OCV
campaign). It was also the first KAP evaluation of a Shanchol OCV campaign in a long-stand-
ing refugee camp. Despite repeated outbreaks and outbreak response efforts in Maela refugee
camp during 2005–2010 [19], baseline cholera knowledge and safe water practices were gener-
ally low (45–70%). At first follow-up, our results showed modest improvements (6–15%
increase) in knowledge of cholera prevention and treatment, as well as reported use and obser-
vation of soap for handwashing in the household, in the absence of a change in the reported
receipt of soap for cholera prevention. These improvements were sustained at second follow-
up, with additional positive and no negative long-term changes noted.
Table 5. (Continued)
Baseline (n = 271) No. %
Fever 3 2
Abdominal pain 1 1
Weakness/fatigue 2 1
a No. of households without children = 43
b Missing data resulted in small fluctuations in denominators for some responses
doi:10.1371/journal.pntd.0005210.t005
Table 6. Oral cholera vaccine (OCV) coverage by survey of household respondents’ recall and individual vaccination cards 3 months after an OCV
campaign (first follow-up), Maela Camp, 2013.
Sourcea Age group (years) Total First dose coverage Second dose coverage
Recall No. No. % LCL UCL No. % LCL UCL
1–4 112 106 95 88 98 95 85 75 91
5–14 307 297 97 91 99 287 93 88 97
15 683 599 88 84 91 557 82 77 85
Total 1102 1002 91 88 93 939 85 81 89
Card
1–4 55 53 96 87 99 47 85 72 93
5–14 126 122 97 91 99 114 90 83 95
15 262 239 91 86 95 212 81 74 86
Total 443 414 93 89 96 373 84 78 89
Abbreviations: LCL = lower confidence limit; UCL = upper confidence limit
a Household respondents’ recall was collected for all household members first, followed by reviewing individual vaccination cards, ("card" responses are the
subset of "recall" with available documentation)
doi:10.1371/journal.pntd.0005210.t006
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Several other cross-sectional evaluations conducted at single time points in endemic and
epidemic cholera settings have similarly documented varying WaSH KAPs [24–26]. The
improvements we observed at first follow-up survey after the OCV campaign were similar to
that of a KAP evaluation in Haiti conducted before and 3 months after an OCV campaign in
2012, the only other pre- and post-campaign KAP evaluation [27]. However, the improve-
ments in cholera knowledge and WaSH behaviors noted in Haiti were more widespread and
pronounced, which may be explained by a more robust cholera and WaSH educational com-
ponent included in the Haiti OCV campaign than in the Maela campaign [27]. A KAP study
in the Solomon Islands also demonstrated high cholera prevention knowledge and behaviors
after WaSH messaging delivered during a targeted OCV campaign [28].
In Maela, the modest KAP improvements at first follow-up generally correlated with the
focus areas for campaign messaging—cholera prevention and handwashing. The majority of
respondents received the proper messaging concerning the limited duration and protection of
OCV, another focus of campaign messaging. More improvements in WaSH knowledge and
practices were observed at second follow-up than first follow-up compared with baseline; like-
wise, reports of hearing about and receiving printed educational materials for cholera preven-
tion increased. The contribution of the OCV campaign to improvements in WaSH KAPs
occurring between the first and second follow-up surveys could not be evaluated relative to the
WaSH educational activities documented to have been conducted by SI during this timeframe.
It is possible that in Maela and similar settings with ongoing WaSH activities (e.g., home visits,
dramas), high-profile OCV campaigns may provide increased visibility to cholera-related
issues that may contribute to people remembering more after the campaign, thereby reinforc-
ing repeated WaSH messaging.
The high anticipated acceptability (97%) and OCV campaign coverage (first dose: 91%; sec-
ond dose: 85%) observed were similar to evaluations from other OCV campaigns [12, 14, 16,
18, 24, 29–33], but higher than previously published coverage estimates from the Maela OCV
campaign based on a vaccination registry (first dose: 83%; second dose: 61%) [19]. Although
assessing vaccination history from recall may introduce bias [34], we observed similarly high
coverage (first dose: 93%; second dose: 84%) among those retaining vaccination cards distrib-
uted before the campaign. Using the most recent census for our survey sampling frame, we
had a high proportion of non-responding households (19%), who may have been more likely
to miss campaign vaccination due to absence. Campaign coverage estimates from the vaccina-
tion registry were more similar to survey estimates calculated under a scenario where all mem-
bers of non-responding households were considered as unvaccinated (first dose: 77%; second
dose: 72%). Results highlight the challenge of working with mobile populations and suggest
OCV campaign coverage among the population continuously residing in the camp may be
higher than previously estimated.
We observed several temporary changes at the first follow-up survey not sustained at the
second follow-up, including decreased observation of safe water containers, increased reported
use of the camp tap as the primary drinking water source, and increased E. coli contamination
of stored household drinking water. Fluctuations in availability of WaSH materials, such as
safe water containers, can occur based on variations in the timing and frequency of their distri-
bution within the camp. While increased fecal contamination of stored drinking water at first
follow-up was correlated with decreased use of safe water containers in households, the tempo-
rary increase could alternatively reflect the shift to the rainy season during May–June that
marks increased opportunities for water contamination and increased use of unsafe water
sources in the camp (F. Cavalazzi, personal communication). E. coli contamination was mod-
erately high and similar between baseline and second follow-up surveys (both occurring in the
dry season), and the amount of residual chlorine detected in stored drinking water was low in
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all three surveys; these results suggest no long-term change in practices which has also been
seen in other studies [35–38]. While conducting a KAP survey soon after the OCV campaign
was important for assessing the temporality of changes, environmental factors and WaSH
behaviors may be impacted by seasonal trends, making assessment of OCV campaign-associ-
ated changes difficult [27].
Our study had some limitations. WaSH KAPs are influenced by multiple factors, and a
direct attribution of observed changes to the OCV campaign is not possible. Social desirability
bias may have led to reporting favorable practices to interviewers who work as CHWs in the
camp. Non-response bias, due to frequent absence and relocation of camp residents, may have
affected outcomes in either direction. Accurate translation of the questionnaire into Burmese
and Karen was made difficult by the existence of multiple dialects and the low education level
among residents in the camp. Despite intensive translation efforts, we discovered one issue
after the baseline survey where translation of the lead-in question “do you do anything to your
drinking water to make it safer?” implied adding something to the water, which may have
resulted in underestimation of water boiling at baseline. The words for “cholera” and “diar-
rhea” are similar in these languages, which may have led to some challenges with interpreta-
tion; however, analysis of responses to equivalent questions for diarrhea and cholera in the
baseline survey suggested that respondents might have found the questions to be redundant
rather than challenging to interpret.
This study demonstrates modest improvements in some reported WaSH-related KAPs and
observed handwashing practices after an OCV campaign in a long-standing refugee camp in
Thailand, both in the short- and long-term (3 and 12 months post-campaign). WaSH remains
the mainstay of cholera prevention and control, but providing OCVs in conjunction with
WaSH interventions may be particularly useful in settings with limited safe water and sanita-
tion infrastructure, such as refugee camps. OCV use has expanded post-licensure, due in part
to WHO initiating an OCV stockpile for epidemic response in 2012, and Gavi, the Vaccine
Alliance providing a financial contribution in 2013 to enable use in low-income countries
[39]. Since OCV campaigns have the potential to be high-profile activities with high accept-
ability and uptake, we recommend planned integration of strong WaSH messaging towards
achieving comprehensive cholera prevention and control in high-risk communities globally.
Further pre- and post-evaluations of the impact of OCV campaigns on WaSH KAPs are
needed from other settings [22]. We recommend including household observations and other
objective measures to distinguish changes in reported KAPs from actual behavior changes.
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